Recent Quotes
My Watchlist
Indicators
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Wave Life Sciences Ltd. - Ordinary Shares (NQ:WVE)

7.860 -0.020 (-0.25%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Wave Life Sciences Ltd. - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9 Next >
Biotech Sector Soars: Promising Drug Trials Ignite Investor Confidence and Spark Market Rally
The biotech sector is currently experiencing a robust rally, a significant turnaround from a period of subdued performance. This resurgence is primarily fueled by a wave of promising drug trial results... 
Via MarketMinute
Topics Artificial Intelligence Intellectual Property
A Look Ahead: WAVE Life Sciences's Earnings Forecast
 
Via Benzinga
Wave Life Sciences to Present at Upcoming Investor Conferences
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
Peering Into WAVE Life Sciences's Recent Short Interest
 
Via Benzinga
Wave Life Sciences Tumbled 19% Today, But Not Everyone’s Disappointed – Find Out Why
Via Stocktwits
Earnings Scheduled For July 30, 2025
 
Via Benzinga
Insights into WAVE Life Sciences's Upcoming Earnings
 
Via Benzinga
Wave Life Sciences to Present Preclinical Data Supporting Therapeutic Potential of WVE-007 for Obesity at ObesityWeek® 2025
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
Wave Life Sciences Third Quarter 2025 Financial Results Scheduled for November 10, 2025
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
Correcting and Replacing Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
Keep an eye on the top gainers and losers in Wednesday's session.
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
Deep Dive Into WAVE Life Sciences Stock: Analyst Perspectives (6 Ratings)
 
Via Benzinga
Wave Life Sciences Announces Virtual Research Day on October 29th and Participation at Upcoming Investor Conferences
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
Top movers analysis one hour before the close of the markets on 2025-09-03: top gainers and losers in today's session.
Curious about what's happening in today's session? Check out the latest stock movements and price changes. 
Via Chartmill
Forecasting The Future: 7 Analyst Projections For WAVE Life Sciences
 
Via Benzinga
Why Is GSK Partner Wave Life Sciences Stock Trading Lower On Wednesday?
Wave Life Sciences shares early WVE-006 trial results in alpha-1 antitrypsin deficiency, reporting durable protein production and favorable safety. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
Crude Oil Falls Over 2%; Campbell's Earnings Top Estimates
 
Via Benzinga
Wednesday's session: gap up and gap down stocks
Today's session on Wednesday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session. 
Via Chartmill
Nasdaq Gains Over 100 Points; Dollar Tree Post Upbeat Earnings
 
Via Benzinga
Which stocks are moving before the opening bell on Wednesday?
Wondering what's happening in Wednesday's pre-market session? Find an overview in this article. 
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
Wave Life Sciences Announces Positive Update from Ongoing RestorAATion-2 Trial of WVE-006 in Alpha-1 Antitrypsin Deficiency
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
This AeroVironment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
 
Via Benzinga
Beyond The Numbers: 6 Analysts Discuss WAVE Life Sciences Stock
 
Via Benzinga
Wave (WVE) Q2 Revenue Drops 56%
Via The Motley Fool
Wave Life Sciences Ltd (NASDAQ:WVE) Reports Q2 2025 Earnings: Revenue Miss but Narrower Loss and Clinical Progress Boost Shares
Wave Life Sciences Q2 2025 results show $8.7M revenue miss but narrower EPS loss. Stock rises on optimism for WVE-006's AATD clinical progress. 
Via Chartmill
Wave Life Sciences Reports Second Quarter 2025 Financial Results and Provides Business Update
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.